Modafinil: Preclinical, Clinical, and Post-Marketing Surveillance—A Review of Abuse Liability Issues

Author： MYRICK HUGH   MALCOLM ROBERT   TAYLOR BRENT   LaROWE STEVEN  

Publisher： Informa Healthcare

ISSN： 1040-1237

Source： Annals of Clinical Psychiatry (after Jan 1, 2004), Vol.16, Iss.2, 2004-01, pp. : 101-109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Post-marketing surveillance of sertindole

By Toumi Mondher  

International Journal of Psychiatry in Clinical Practice, Vol. 6, Iss. 1, 2002-12 ,pp. : 33-35

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Risperidone in the treatment of affective spectrum disorders and schizophrenia: a large, multicenter post-marketing surveillance study

By Park Jong-Ik   Kim Chang Yoon   Lee Jun Young   Hong Jin Pyo  

Primary Care Psychiatry, Vol. 9, Iss. 4, 2004-12 ,pp. : 131-136

Informa Healthcare

Access to resources Recommend Favorite

Particular aspects of adverse event assessment in post marketing surveillance

By Baier D.  

European Psychiatry, Vol. 13, Iss. 3, 1998-05 ,pp. : 164-170

Elsevier

Access to resources Recommend Favorite

Liability Issues Associated With the Administration of Allergen Immunotherapy

By Putman Heidi   Badzek Laurie  

Journal of Nursing Law, Vol. 10, Iss. 2, 2005-01 ,pp. : 131-136

Springer Publishing Company

Access to resources Recommend Favorite

Selective vulnerability of cerebellar granule neuroblasts and their progeny to drugs with abuse liability

By Hauser Kurt F   Khurdayan Valeriya K   Goody Robin J   Nath Avindra   Saria Alois   Pauly James R  

The Cerebellum, Vol. 2, Iss. 3, 2003-09 ,pp. : 184-195

Informa Healthcare

Access to resources Recommend Favorite